| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-10 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |